AHA 2023 Insights

 

 
 

 

AHA 2023 Insights: ARO-ANG3, an Investigational RNAi Therapeutic, Silences the Expression of ANGPTL3 and Decreases Atherogenic Lipoproteins in Patients With Mixed Dyslipidemia - ARCHES-2 Study Results

303 views
November 23, 2023
Comments 0
Login to view comments. Click here to Login